In other words, beneficial effects of leptin in CVD can be observed, but, in most cases, hyperleptinemia (especially when associated with obesity) exerts detrimental effects on CV function and promotes adverse outcomes in CV disorders, making it a significant marker for CV disorders in the obese population. The gene discussed is LEP; the disease is obesity disorder.